ClinicalTrials.Veeva

Menu

Intraurethral Lidocaine After Endourology Procedures

S

San Antonio Uniformed Services Health Education Consortium

Status and phase

Terminated
Phase 3

Conditions

Dysuria

Treatments

Drug: Lidocaine Jet Injector
Drug: Placebos

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT03537534
C.2018.055d

Details and patient eligibility

About

Many urological conditions are diagnosed and treated with the use of endourology procedures. Unfortunately, dysuria is a common patient complaint following these procedures. Intraurethral lidocaine instillation is regularly used prior to office-based endourology procedures to alleviate dysuria, as well as, discomfort during the procedure.. Studies have confirmed that office-based procedures using intraurethral lidocaine have resulted in less patient reported dysuria. Many endourology procedures are done under general anesthesia such as urinary stone treatments or resection of bladder tumors. There is a paucity of data regarding the use of intraurethral lidocaine at the conclusion of these procedures evaluating patient reported dysuria. We have designed a prospective, randomized, placebo controlled trial to evaluate the role of intraurethral lidocaine instillation following endourology procedures in the anesthetized patient.

Enrollment

35 patients

Sex

All

Ages

18 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Adult patients, age 18 and older scheduled to undergo endourologic procedure to include ureteroscopy, rigid diagnostic cystoscopy, bladder biopsy, laser lithotripsy, cystolithalopaxy, and transurethral resection of bladder tumor in the operating room under general anesthesia.

Exclusion Criteria: active urinary tract infection, current dysuria symptoms, pregnant females, urethral stricture disease, indwelling foley catheter, and history of pelvic radiation

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

35 participants in 2 patient groups, including a placebo group

Experiment
Experimental group
Description:
Lidocaine jelly (2%) 5mL x 1 dose only
Treatment:
Drug: Lidocaine Jet Injector
Placebo
Placebo Comparator group
Description:
Surgilube 5mL x 1 dose only
Treatment:
Drug: Placebos

Trial contacts and locations

1

Loading...

Central trial contact

Christopher L Allam, DO; Felicia Balzano, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems